Company information:
Zakari Therapeutics Limited (No: 13408042)
Address: BELLHOUSE BUILDING, SANDERS ROAD, OXFORD, OX4 4GD, ENGLAND
Status: Active - Proposal to Strike off
Incorporated: 19-May-2021
Accounts Next Due: 31-Jan-2023
Next Confirmation Statement Due: 31-May-2023
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: SALLY ELIZABETH ADAMS ( DOB: Jun-1960 From: May-2021 )
Current Director: JOHN CHIPLIN ( DOB: Nov-1958 From: May-2021 )
Current Director: LINDA GILLIAN DURRANT ( DOB: Aug-1957 From: May-2021 )
Current Director: CLIFF HOLLOWAY ( DOB: Mar-1960 From: May-2021 )
Current Secretary: KEITH CHARLES GREEN ( From: May-2021 )
Resigned Director: RICHARD MORLEY GOODFELLOW ( DOB: Apr-1950 From: May-2021 To: Nov-2022 )
Resigned Director: CLIFF HOLLOWAY ( DOB: Mar-1960 From: May-2021 To: Jul-2021 )
Persons of Significant Control:
Scancell Limited, John Eccles House Robert Robinson Avenue, Oxford, OX4 4GP, England: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2021-05-19)